Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunome (IMNM) Other Non-Current Assets: 2023-2025

Historic Other Non-Current Assets for Immunome (IMNM) over the last 3 years, with Sep 2025 value amounting to $4.6 million.

  • Immunome's Other Non-Current Assets rose 4455.00% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year increase of 4455.00%. This contributed to the annual value of $4.4 million for FY2024, which is 4311.00% up from last year.
  • Latest data reveals that Immunome reported Other Non-Current Assets of $4.6 million as of Q3 2025, which was up 4.62% from $4.4 million recorded in Q2 2025.
  • Immunome's Other Non-Current Assets' 5-year high stood at $4.6 million during Q3 2025, with a 5-year trough of $100,000 in Q1 2023.
  • For the 3-year period, Immunome's Other Non-Current Assets averaged around $1.7 million, with its median value being $100,000 (2024).
  • Data for Immunome's Other Non-Current Assets shows a peak YoY surged of 4,455.00% (in 2025) over the last 5 years.
  • Quarterly analysis of 3 years shows Immunome's Other Non-Current Assets stood at $100,000 in 2023, then soared by 4,311.00% to $4.4 million in 2024, then spiked by 4,455.00% to $4.6 million in 2025.
  • Its last three reported values are $4.6 million in Q3 2025, $4.4 million for Q2 2025, and $4.3 million during Q1 2025.